Biotech Investors & VC Firms in Europe
841 firms in this list, with a median first check of $500K. 192 of them lead rounds. Generated from verified public data and updated continuously.
Blue Ocean Capital Group
ShenzhenLate Stage
23 people
ZAKA VC
San FranciscoPre-Seed–Series A
1 person
Georgian
Toronto, OntarioSeries B–Late Stage$25M – $100M
12 people
Epidarex Capital
BethesdaPre-Seed–Series A$2.5M – $6.3M
12 people
Xeraya Capital
Kuala LumpurSeed–Growth
24 people
Astellas Venture Management LLC
South San FranciscoSeed–Growth$200K – $5M
10 people
H.I.G. HealthBridge Partners
MiamiGrowth$5M – $40M
15 people
Omega Funds
BostonSeed–Late Stage
21 people
Dimension Capital
San FranciscoSeed–Late Stage$1M – $10M
14 people
SAV (Scale Asia Ventures)
Palo AltoSeed–Series B
12 people
BIOSPRING PARTNERS
New YorkGrowth–Late Stage
22 people
Rhapsody Venture Partners
CambridgePre-Seed–Seed$500K – $2M
10 people
New Mountain Capital
New YorkGrowth–Late Stage
6 people
Regeneration.VC
Redondo BeachSeed–Series B$1M – $3M
9 people
Starship Ventures
San FranciscoPre-Seed–Seed
14 people
Quan Capital
ShanghaiSeed–Late Stage
16 people
Expara
SingaporePre-Seed–Series A$320K – $600K
18 people
Asahi Kasei Corporate Venture Capital
Menlo ParkPre-Seed–Late Stage$500K – $3M
21 people
REMUS Capital
BostonPre-Seed–Series B$25K – $20M
9 people
JK&B Capital
ChicagoPre-Seed–Late Stage
10 people
Noetic
TorontoSeed–Series A
13 people
Teralys Capital
MontrealGrowth
23 people
Entrada Ventures
Santa BarbaraPre-Seed–Series B
10 people
Sonder Capital
San CarlosPre-Seed–Late Stage
15 people
Related lists
Investors & VC Firms in North America (13845)Investors & VC Firms in United States (12980)Investors & VC Firms in Europe (5528)Crypto & Web3 Investors & VC Firms (4819)Investors & VC Firms in Global (4182)SaaS Investors & VC Firms (3878)AI & Machine Learning Investors & VC Firms (3817)Fintech Investors & VC Firms (3737)Investors & VC Firms in Asia-Pacific (3575)Healthtech Investors & VC Firms (3445)
Data sourced from public filings and firms' own websites — see our methodology.































































































